Pablo Corral: How Low Should LDL-C Go After Ischemic Stroke?
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared on LinkedIn about a recent article by Victorien Monguillon et al, published in Circulation:
”How Low Should LDL-C Go After Ischemic Stroke?
Not theoretical anymore. Not opinion.
Data:
- Lower LDL-C, fewer cardiovascular events
- Lower LDL-C, fewer recurrent strokes
- Benefit continues below 40 mg/dL
And importantly:
- No excess hemorrhagic stroke
- No safety signal
- Consistent risk reduction
The real question is no longer how low is too low. It is:
Why are we still leaving stroke patients exposed to avoidable LDL risk?
After ischemic stroke: Aggressive LDL lowering is prevention
Title: Efficacy and Safety of Very Low Achieved LDL Cholesterol in Patients With Previous Ischemic Stroke
Authors: Victorien Monguillon, Peter Kelly, Michelle O’Donoghue, Jeong-Gun Park, Erin Bohula, Jeffrey Saver, Dan Atar, Anthony Keech, Peter Sever, Huei Wang, Gabriel Paiva da Silva Lima, Marc Sabatine, Robert Giugliano
Read the Full Article on Circulation
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 17, 2026, 08:32Leslie Johns: Our First Low Titer O Whole Blood Products
-
Apr 17, 2026, 08:24Dominique P. Germain: The Critical Role of Cardiac Involvement in Fabry Disease
-
Apr 17, 2026, 07:54Pat Garcia-Gonzalez: Does Having Lifesaving Medicine at a Hospital Guarantee Patient Access?
-
Apr 17, 2026, 05:41Tareq Abadl: Sickle Cell Anemia is Not Just Hemoglobin Deficiency, It’s a Genetic Mutation
-
Apr 17, 2026, 04:58Emmanuel J Favaloro: A Century of von Willebrand Disease – From Discovery to Modern Diagnostic Pathways
-
Apr 17, 2026, 02:41Helena Bradbury: First Haematology EAHAD Supplement of 2026
-
Apr 16, 2026, 18:27Are We Underestimating VTE After PanNET Surgery? – RPTH Journal
-
Apr 16, 2026, 16:10Hamid Noori: Understanding the Cause of Anemia through Etiological Classification
-
Apr 16, 2026, 15:29Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis